Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
Patientory is a patient data platform that empowers individuals to control their health data and earn personalized rewards.
Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.
Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Xealth is a digital health platform that enables healthcare organizations to prescribe and monitor health tools, programs, and services.
Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.
Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.
Deciphex builds a network of AI empowered pathologists ensuring accessible pathology services that improves patient outcomes.
Credence MedSystems is a drug delivery and specialty pharmaceutical company focused on delivering medications safely.
Borealis Biosciences is a company in the field of next-generation RNA medicines.
Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.
Cleerly is a digital healthcare company that offers heart disease diagnosis solutions.
LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington's disease.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.
SaaS AI/ML platform providing real-time voice and telecare to people with neurological disorders
FundaMental Pharma is a neuroscience company with a portfolio at the preclinical stage.
Lightship is making clinical trials more accessible for patients and providers to accelerate development of better therapies for all.
A UK-based developer of drugs to treat respiratory diseases
Novartis has invested in 99 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novartis's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Health Diagnostics. The firm invests across 26 different industry categories.
Among tracked funding rounds, Intellia Therapeutics received $400.0M in a Post-IPO Debt round. Novartis's total known invested capital is $3.8B.
Novartis's average investment size is $60.5M across its portfolio of 99 companies.
Recent Novartis portfolio additions include Intellia Therapeutics, Freenome, Patientory, Relation Therapeutics, Rani Therapeutics. These companies were founded in 2020 or later.